Elekta AB Unsponsored American Depositary Receipt (EKTAY)
OTC
Closed
Aug 26, 2026
Day's Range
5.7252 wk Range
4.35Overview - EKTAY - Elekta AB Unsponsored American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
6.34B
P/E (Trailing)
‪75.62‬
PEG Ratio
‪0.60‬
Price / Sales (TTM)
‪0.13‬
Price / Book
‪0.26‬
EV / EBITDA
‪4.18‬
Profitability
Gross Margin
‪39.52%‬
Profit Margin
‪-3.10%‬
Operating Margin
‪0.97%‬
Return on Assets
‪3.05%‬
Return on Equity
‪-6.45%‬
Ownership
Shares Outstanding
382.08M
Float
311.09M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.96‬
50-Day Avg
‪5.17‬
200-Day Avg
‪5.74‬
Dividends
Payout Ratio
‪327.57%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - EKTAY - Elekta AB Unsponsored American Depositary Receipt
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
Profile Summary - EKTAY - Elekta AB Unsponsored American Depositary Receipt
About
Elekta AB Unsponsored American Depositary Receipt represents shares in Elekta AB, a Swedish medical technology company that develops and provides advanced clinical solutions for the treatment of cancer and brain disorders. Through its specialized radiotherapy, brachytherapy, and neurosurgery products—including the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
